Founded in Fort Collins, United States, KromaTiD is dedicated to advancing the understanding of genetic abnormalities and diseases through the development of innovative molecular cytogenetics assays and reagents. The company offers a range of products including FISH probes, HD chromosome paints, and specialized kits like the TP53/CEP17 kit. Their services encompass G-band karyotyping, single-cell based assays, and whole genome assays, targeting researchers and clinicians focused on genetic research and diagnostics.
KromaTiD has made significant strides in the field of genetic analysis, with notable contributions from experts in molecular biology and genetics. The company has attracted investment from key players in the biotech industry, bolstering its research capabilities and market reach. KromaTiD's innovative assays have been instrumental in advancing genetic research, providing critical tools for identifying and understanding genetic disorders, thereby making a substantial impact on both scientific research and clinical diagnostics.
